The Latest Stem Cell Counting News From Asymmetrex®
Asymmetrex® continues to lead a long-needed reformation in stem cell science and medicine with the development and introducton of innovative biotechnologies for routine, accurate, differential counting of tissue stem cells.
Asymmetrex® Featured in Drug Development World Perspective Highlighting the Company's Development of Kinetic Stem Cell Counting and the Use of the Technology to Make Transformative Discoveries in Tissue Stem Cell Biomanufacturing.
Asymmetrex® Co-Authors Stem Cells International Report That Uses Its KSC Counting Technology to Discover the Biological Basis for Variable Success in Mesenchymal Stem Cell Expansion
ASTM Standard F3716-25, Whose Drafting Was Led by Asymmetrex®, Recognized by FDA CBER as a Voluntary Consensus Standard for Regenerative Medicine Product Development
Asymmetrex® CEO Awarded Robert E. Fairer Award by ASTM Subcommittee F04.43 for Leadership in Establishing New Industry Standards for Cell Therapy and Regenerative Medicine
Asymmetrex® Publishes Feature Article on BiteSize Bio Detailing the Development of New ASTM Standards for Greater Precision in Cell Proliferation Analyses and Differential Tissue Stem Cell Counting
Asymmetrex® CEO Discusses Why Innovation in Automation and Standardization of Proliferation Rate Measurements for Stock Cell Cultures Will Benefit Cell Science and Medicine
Asymmetrex® Leads ASTM International Working Group to Draft New Standard for Differential Tissue Stem Cell Counting
Asymmetrex® Leads ASTM International Working Group to Establish New Standard for Cell Proliferation Rate Measurement
Asymmetrex® Presents the Impact of Differential Stem Cell Counting for Cultured Meat Production
TechCompanyNews Feature Article: Asymmetrex Awarded $1.8M NIH-NHLBI SBIR Phase II Grant To Build Automated Tissue Stem Cell Counter
October 8, 2024 – https://www.techcompanynews.com/asymmetrex-awarded-1-8m-nih-nhlbi-sbir-phase-ii-grant-to-build-automated-tissue-stem-cell-counter/
Asymmetrex Awarded $1.8M NIH-NHLBI SBIR Phase II Grant To Build Automated Tissue Stem Cell Counter
Asymmetrex Awarded $1.8M NIH-NHLBI SBIR Phase II Grant To Build Automated Tissue Stem Cell Counter
Asymmetrex® Awarded $1.8M NIH-NHLBI SBIR Phase II Grant to Manufacture First Differential Tissue Stem Cell Counter
October 2, 2024 – https://www.einpresswire.com/article/747830516
Asymmetrex® Begins New Year with a New Report Demonstrating the Precision of Its Stem Cell Dosing Technology
New Report: Asymmetrex® Stem Cell Counting Technology Used to Confirm Suspected Variability in Stem Cell Preparations
Asymmetrex® Talks with Tech Company News about New Stem Cell Calculators
Asymmetrex® Announces Free Online Calculators for Quantifying Therapeutic Stem Cells
Asymmetrex® Partners to Develop New Mobile App for Stem Cell Science in Indian Livestock and Dairy Industry
Asymmetrex® Publishes First Rating of the Effects of Commercial Growth Factors Used for Stem Cell Biomanufacturing
Asymmetrex® Announces Plan to Develop the First Automated Electronic Cell Counter for Therapeutic Stem Cells
We promise we don’t send spam